Ponticelli, Claudio http://orcid.org/0000-0001-6060-965X
Glassock, Richard J.
Article History
Received: 15 February 2019
Accepted: 21 March 2019
First Online: 29 March 2019
Compliance with ethical standards
:
: Dr Ponticelli has no conflict of interest to disclose. Dr. Glassock is a compensated consultant to Bristol-Myers Squibb, Genentech, Chemocentryx, Mallinckrodt, Apellis, Ionis, Achillion, Omeros. He also receives a stipend from Wolters -Kluwer (UpToDate) and Karger Publications (American Journal of Nephrology and Nephrology Viewpoints) for Editorial Services. He owns stock in REATA, Inc. (Bardoxolone).
: This article does not contain any studies with human participants performed by any of the authors.
Free to read: This content has been made available to all.